美国心肌梗死后高强度他汀使用的性别差异
该研究基于MarketScan和Medicare数据库,分析2014至2015年心梗出院后30天内他汀处方填充情况,发现女性填充高强度他汀的比例低于男性,调整后风险比为0.91,且在多个亚组中差异持续存在。
要点
- 心梗后女性填充高强度他汀的比例低于男性。
- 总人群调整后女性与男性风险比为0.91。
- 年轻和年老及无合并症者性别差异最大。
核心结论
- 尽管近期努力减少指南推荐治疗的性别差异,女性心梗后填充高强度他汀处方的可能性仍低于男性。
研究设计与样本
- 研究纳入MarketScan数据库中16,898例<65岁有商业保险的美国成人(26%女性)和Medicare数据库中71,358例≥66岁有政府保险的美国成人(49%女性),均为2014至2015年心梗出院后30天内填充他汀处方者。
主要发现
- 2014至2015年,56%的男性和47%的女性在心梗出院后填充了高强度他汀。
- 总人群调整后女性与男性填充高强度他汀的风险比为0.91(95%CI:0.90至0.92)。
- 无既往他汀使用者中调整风险比为0.91(95%CI:0.89至0.92)。
- 既往使用低/中等强度他汀者调整风险比为0.87(95%CI:0.85至0.90),既往使用高强度他汀者调整风险比为0.98(95%CI:0.97至1.00)。
- 所有分析的亚组中女性填充高强度他汀的可能性均低于男性,差异在最年轻和最年长成人及无普遍合并症者中最大。
关键数值与推荐
- 高强度他汀定义为阿托伐他汀40至80 mg和瑞舒伐他汀20至40 mg。
临床怎么用
- 临床医生应关注心梗后女性患者高强度他汀的处方填充情况,尤其年轻、年老及无合并症者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Historically, women have been less likely than men to receive guideline-recommended statin therapy for the secondary prevention of myocardial infarction (MI). OBJECTIVES: The authors examined contemporary sex differences in prescription fills for high-intensity statin therapy following an MI, overall and across population subgroups, and assessed whether sex differences were attenuated following recent efforts to reduce sex disparities in the use of cardiovascular disease preventive therapies. METHODS: The authors studied 16,898 (26% women) U.S. adults <65 years of age with commercial health insurance in the MarketScan database, and 71,358 (49% women) U.S. adults ≥66 years of age with government health insurance through Medicare who filled statin prescriptions within 30 days after hospital discharge for MI in 2014 to 2015. The authors calculated adjusted women-to-men risk ratios and 95% confidence intervals (CIs) for filling a high-intensity statin prescription (i.e., atorvastatin 40 to 80 mg, and rosuvastatin 20 to 40 mg) following hospital discharge for MI. RESULTS: In 2014 to 2015, 56% of men and 47% of women filled a high-intensity statin following hospital discharge for MI. Adjusted risk ratios for filling a high-intensity statin comparing women with men were 0.91 (95% CI: 0.90 to 0.92) in the total population, 0.91 (95% CI: 0.89 to 0.92) among those with no prior statin use, and 0.87 (95% CI: 0.85 to 0.90) and 0.98 (95% CI: 0.97 to 1.00) for those taking low/moderate-intensity and high-intensity statins prior to their MI, respectively. Women were less likely than men to fill high-intensity statins within all subgroups analyzed, and the disparity was largest in the youngest and oldest adults and for those without prevalent comorbid conditions. CONCLUSIONS: Despite recent efforts to reduce sex differences in guideline-recommended therapy, women continue to be less likely than men to fill a prescription for high-intensity statins following hospitalization for MI.
引用
- Peters SAE, Colantonio LD, Zhao H, et al. Sex Differences in High-Intensity Statin Use Following Myocardial Infarction in the United States. J Am Coll Cardiol. 2018. PMID: 29673463. doi:10.1016/j.jacc.2018.02.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。